List of SBIR/STTR awards granted to LENTIGEN CORPORATION

List of SBIR/STTR awards granted to LENTIGEN CORPORATION

List of SBIR/STTR awards granted to Level Set Systems

List of SBIR/STTR awards granted to Archinoetics, LLC

List of SBIR/STTR awards granted to Opterus Research and Development, Inc.

List of companies founded by Shervin Pishevar

List of companies in Blue Chip Venture Company's investment portfolio

where

SBIR/STTR Award Recipient

is

‌

LENTIGEN CORPORATION

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ LENTIGEN CORPORATION STTR Phase I Award, August 2007	A STTR Phase I contract was awarded to LENTIGEN CORPORATION in August, 2007 for $98,514.0 USD from the U.S. Department of Defense.	‌ LENTIGEN CORPORATION	U.S. Department of Defense		STTR	W911SR-07-P-0046	Phase I	98,514	August 16, 2007	sbir.gov/content/modular-protein-manufacturing-platform-0
	‌ LENTIGEN CORPORATION STTR Phase II Award, September 2008	A STTR Phase II contract was awarded to LENTIGEN CORPORATION in September, 2008 for $748,524.0 USD from the U.S. Department of Defense.	‌ LENTIGEN CORPORATION	U.S. Department of Defense		STTR	W911SR-08-C-0080	Phase II	748,524	September 26, 2008	sbir.gov/content/modular-protein-manufacturing-platform-2
	‌ LENTIGEN CORPORATION SBIR Phase I Award,	A SBIR Phase I contract was awarded to LENTIGEN CORPORATION for $289,677.0 USD from the U.S. Department of Health & Human Services.	‌ LENTIGEN CORPORATION			SBIR	1R43AI073097-01	Phase I	289,677		sbir.gov/content/lentiviral-vectors-tcr-immunotherapy-targeted-hcv-0
	‌ LENTIGEN CORPORATION SBIR Phase I Award,	A SBIR Phase I contract was awarded to LENTIGEN CORPORATION for $243,003.0 USD from the U.S. Department of Health & Human Services.	‌ LENTIGEN CORPORATION			SBIR	1R43CA126461-01	Phase I	243,003		sbir.gov/content/lentiviral-vectors-tcr-immunotherapy-targeted-melanoma-0
	‌ LENTIGEN CORPORATION SBIR Phase I Award,	A SBIR Phase I contract was awarded to LENTIGEN CORPORATION for $282,918.0 USD from the U.S. Department of Health & Human Services.	‌ LENTIGEN CORPORATION			SBIR	1R43AI084310-01	Phase I	282,918		sbir.gov/content/novel-method-generating-hepatitis-c-virus-particles-using-lentivirus-0
	‌ LENTIGEN CORPORATION STTR Phase I Award,	A STTR Phase I contract was awarded to LENTIGEN CORPORATION for $283,753.0 USD from the U.S. Department of Health & Human Services.	‌ LENTIGEN CORPORATION			STTR	1R41CA130547-01	Phase I	283,753		sbir.gov/content/lentiviral-redirected-t-cells-b-cancer-immunotherapy-0
	‌ LENTIGEN CORPORATION SBIR Phase I Award,	A SBIR Phase I contract was awarded to LENTIGEN CORPORATION for $264,329.0 USD from the U.S. Department of Health & Human Services.	‌ LENTIGEN CORPORATION			SBIR	1R41AI071927-01	Phase I	264,329		sbir.gov/node/1069881
	‌ LENTIGEN CORPORATION SBIR Phase I Award,	A SBIR Phase I contract was awarded to LENTIGEN CORPORATION for $236,588.0 USD from the U.S. Department of Health & Human Services.	‌ LENTIGEN CORPORATION			SBIR	1R43CA124273-01	Phase I	236,588		sbir.gov/content/lentiviral-engineered-t-cell-immunotherapy-tumors-overexpressing-mesothelin-0
	‌ LENTIGEN CORPORATION SBIR Phase I Award,	A SBIR Phase I contract was awarded to LENTIGEN CORPORATION for $114,645.0 USD from the U.S. Department of Health & Human Services.	‌ LENTIGEN CORPORATION			SBIR	1R43CA124274-01	Phase I	114,645		sbir.gov/content/immunotherapy-cll-lentiviral-expressed-cd40-ligand-0
	‌ LENTIGEN CORPORATION SBIR Phase I Award,	A SBIR Phase I contract was awarded to LENTIGEN CORPORATION for $134,081.0 USD from the U.S. Department of Health & Human Services.	‌ LENTIGEN CORPORATION			SBIR	1R43CA130294-01	Phase I	134,081		sbir.gov/content/t-cell-receptor-gene-vectors-ebv-disease-0
	‌ LENTIGEN CORPORATION SBIR Phase II Award,	A SBIR Phase II contract was awarded to LENTIGEN CORPORATION for $5,118,190.0 USD from the U.S. Department of Health & Human Services.	‌ LENTIGEN CORPORATION			SBIR	2R44CA126461-02A1	Phase II	5,118,190		sbir.gov/content/clinical-vector-tcr-immunotherapy-targeted-melanoma
	‌ LENTIGEN CORPORATION SBIR Phase I Award,	A SBIR Phase I contract was awarded to LENTIGEN CORPORATION for $119,144.0 USD from the U.S. Department of Health & Human Services.	‌ LENTIGEN CORPORATION			SBIR	1R43AR054291-01A2	Phase I	119,144		sbir.gov/content/lentiviral-expressed-growth-factors-novel-therapy-wound-healing-0
	‌ LENTIGEN CORPORATION STTR Phase I Award,	A STTR Phase I contract was awarded to LENTIGEN CORPORATION for $264,329.0 USD from the U.S. Department of Health & Human Services.	‌ LENTIGEN CORPORATION			STTR	1R41AI071927-01	Phase I	264,329		sbir.gov/content/suicide-hiv-infected-cells-tat-inducible-shrna-0
	‌ LENTIGEN CORPORATION SBIR Phase I Award,	A SBIR Phase I contract was awarded to LENTIGEN CORPORATION for $140,720.0 USD from the U.S. Department of Health & Human Services.	‌ LENTIGEN CORPORATION			SBIR	1R43CA141738-01	Phase I	140,720		sbir.gov/content/universal-muc1-targeted-immunotherapy-0
	‌ LENTIGEN CORPORATION STTR Phase I Award,	A STTR Phase I contract was awarded to LENTIGEN CORPORATION for $2,652,660.0 USD from the U.S. Department of Health & Human Services.	‌ LENTIGEN CORPORATION			STTR	1R42CA128269-01A2	Phase I	2,652,660		sbir.gov/node/378694
	‌ LENTIGEN CORPORATION STTR Phase I Award,	A STTR Phase I contract was awarded to LENTIGEN CORPORATION for $364,844.0 USD from the U.S. Department of Health & Human Services.	‌ LENTIGEN CORPORATION			STTR	1R41DK085944-01	Phase I	364,844		sbir.gov/node/378412

16 results

0 selected

16 results

0 selected